The present description relates generally to systems and methods for a sensor system for the detection of an analyte in a sample, and more specifically to compensating for signal variations impacting the detection of analytes.
Biosensors may allow for the detection of a given specific target molecule, referred to an analyte, within a sample, wherein the amount or concentration of said analyte is typically small, sometimes in the range of nanograms per milliliter. To detect these molecules, functionalized labels or detection tags, such as enzymes, fluorophores, or magnetic beads, may be utilized. In a magnetic-label biosensor, measuring the presence of the analyte (such as drugs or cardiac markers) is based on molecular capture and labeling with magnetic particles or beads. The magnetic beads may be arranged in a sample chamber of a sample cartridge. At least a portion of a sensor surface in the sample chamber is prepared for the detection of the analyte. For example, the sensor surface may include one or more regions where capture elements that are configured to bind to analyte are fixed (e.g., antibodies). For performing the test, a sample is loaded in the cartridge, and any analyte in the sample will bind both the magnetic beads and the capture elements on the binding surface.
Magnetic attraction of the beads, also referred to as actuation, may increase the performance, e.g., speed, of the biosensor for point-of-care applications. The direction of the magnetic attraction can be either towards the surface where the actual measurement is carried out or away from this surface. In the first case magnetic actuation allows the enhancement of the concentration of magnetic particles near the sensor surface (where the magnetic particles may bind to a corresponding capture element, such as an antibody, on the sensor surface via the analyte), speeding up the binding process of the magnetic particles at the sensor surface. In the second case, unbound magnetic particles (e.g., magnetic particles that are not bound to a capture element on the sensor surface) are removed from the surface which is called magnetic washing. Once magnetic washing is complete, the concentration of the analyte in the sample may be determined by measuring the number of magnetic beads bound to the capture elements on the sensor surface. For example, a light source may be directed to a region of the sensor surface where the capture elements are fixed so as to generate light that is totally internally reflected. The magnetic particles at the sensor surface may scatter and/or absorb the totally internally reflected light, which may be detected by a detector and used to determine the concentration of the target molecule in the sample.
In one embodiment, a sensor system includes a sample container configured to receive a sample containing an analyte to be tested, the sample container comprising a detection surface and a plurality of signal generating elements in the sample container, wherein the detection surface comprises a binding surface, which has been partially functionalized with capture elements that can bind, directly and/or indirectly, the analyte and/or the plurality of signal generating elements. The sensor system further includes a memory storing instructions executable by a processor to obtain background data comprising sensor signals from one or more background regions of the detection surface, obtain sample data comprising sensor signals from the binding surface, and perform a correction of the sample data based on the background data.
To the accomplishment of the foregoing and related ends, certain illustrative aspects of the system are described herein in connection with the following description and the attached drawings. The features, functions, and advantages that have been discussed can be achieved independently in various embodiments of the present disclosure or may be combined in yet other embodiments, further details of which can be seen with reference to the following description and drawings. The summary is provided to introduce a selection of concepts in a simplified form that are further described below in the Detailed Description. This summary is not intended to identify key features or essential features of any subject matter described herein.
The following description relates to systems and methods for a sensor system, also referred to as a microfluidic testing system or microelectronic sensor system. The sensor system may be a magnetic sensor system including one or more sample containers loaded with functionalized signal generating elements, e.g., antibody-labeled magnetic particles, that are configured to bind to a specific target molecule (also referred to herein as an analyte or analyte of interest) such as troponin or B-type natriuretic peptide (BNP). Each sample container has a sensor detection surface that is also functionalized, e.g., with the same and/or different antibodies as those bound to the signal generating elements, to form a binding surface on the detection surface. To measure the concentration of the analyte in a sample such as blood or saliva, the sample is provided in the sample container, where the sample mixes with the signal generating elements. In this way, the signal generating elements may bind to the sensor binding surface via the analyte, with the number of signal generating elements that bind to the sensor binding surface being a function of the concentration of the analyte.
In examples where the sensor system is a magnetic sensor system, the signal generating elements may be magnetic particles and one or more magnetic elements may be positioned outside the sample container (e.g., below the sample container), and a magnetic field generated by the one or more magnetic elements may attract the magnetic particles to the sensor binding surface to expedite binding of the magnetic particle/analyte complexes to the sensor binding surface. The area of the sensor binding surface that binds the magnetic particle/analyte complexes may thus be based on the size and position of the magnetic element, as well any variations in the magnetic field generated by the magnetic element. Typically, the antibodies/capture elements are fixed to the sensor detection surface in discrete areas, such as discrete patches or spots. Further, some sample containers may be configured to facilitate detection of the concentration of more than one analyte, and thus different capture elements may be present in different binding surface areas. Accordingly, the positioning of the binding surface areas may be based on the magnetic field generated by the magnetic element. For example, if the magnetic field has a highest magnetic flux density at the center of the sensor detection surface, the binding surface may be positioned at the center of the sensor detection surface. In doing so, the magnetic elements may concentrate at and near the binding surface areas, which may increase the signal measured by the detector.
However, other forces also act on the signal generating elements, such as gravitational forces and/or forces generated during movement of the sensor system, which may influence the behavior of the signal generating elements during sample testing and thereby lead to result variations. Further, the mobility of the signal generating elements may be affected by the fluid of the sample being tested. For example, the viscosity of the sample fluid or the content of other substances in the sample fluid, such as sucrose or proteins, may influence the mobility of the signal generating elements as well as the optical signals produced by the signal generating elements that are measured to determine the concentration of the analyte.
As a result of the gravitational and/or other forces acting on the signal generating elements as well as the influence on signal generating element mobility from the sample fluid, signal generating element distribution may not be equal across the binding surface. This uneven signal generating element distribution may result in unreliable test measurements, particularly when more than one type of capture element is present on the sensor binding surface. Further, because the composition of the sample fluid may vary from sample to sample (e.g., some patients may have high blood sugar while other patients may have lower blood sugar), the influence on the optical signals of the signal generating elements by the fluid composition may result in test to test variations, which may also reduce test reliability.
Thus, according to embodiments disclosed herein, sample optical signals obtained during a detection phase of a test of a sample with a sensor system in order to measure the concentration of an analyte in the sample may be corrected with background optical signals obtained during a biochemical reaction phase that may precede the detection phase where the sample optical signals are obtained. The biochemical reaction phase may include periods where a magnetic element of the sensor system is activated to pull the magnetic particles to the sensor binding surface, and may occur prior to a final magnetic wash where the unbound magnetic beads are moved away from the sensor binding surface. By measuring the signal from the magnetic beads during the biochemical reaction phase where the magnetic beads are attracted to the sensor binding surface, the combined effects of the sample fluid properties and magnetic particle distribution inhomogeneities that can influence the sample optical signal response can be measured and used to directly correct the sample optical signal response measured at the binding surface (e.g., the sample optical signals). Further, the background optical signals may be obtained from a plurality of background regions of the detection surface that do not overlap with the binding surface areas (at least partially). In doing so, the background optical signals are not influenced by the analyte concentration, which influences the signal response within the binding surface areas during the biochemical reaction phase (e.g., during the biochemical reaction phase, the signal response will increase over time dependent on the analyte concentration). However, in some examples, the background regions may overlap the binding surface, and the presence of bound signal generating elements may be accounted for by subtracting out the sample data from the background data.
The interface between the carrier 11 and the sample chamber 2 is formed by a surface referred to as a detection surface 12. This detection surface 12 may be coated with capture elements, e.g. antibodies, which can specifically bind the target components. Additional details regarding the coating of the detection surface 12 with capture elements is provided below.
The sensor system 100 comprises a magnetic field generator 41, for example an electromagnet with a coil and a core, for controllably generating a magnetic field B at the detection surface 12 and in the adjacent space of the sample chamber 2. With the help of this magnetic field B, the signal generating elements 1 can be manipulated, i.e. be magnetized and particularly be moved (if magnetic fields with gradients are used). Thus it is for example possible to attract signal generating elements 1 to the detection surface 12 in order to accelerate the binding of the associated target component to the detection surface 12.
The sensor system 100 further comprises a light source 21, for example a laser or a light emitting diode (LED), that generates an input light beam L1 which is transmitted into the carrier 11. The input light beam L1 arrives at the detection surface 12 at an angle larger than the critical angle θc of total internal reflection (TIR) and is therefore totally internally reflected as an output light beam L2. The output light beam L2 leaves the carrier 11 through another surface and is detected by a light detector 31, e.g. a photodiode. The light detector 31 determines the amount of light of the output light beam L2 (e.g. expressed by the light intensity of this light beam in the whole spectrum or a certain part of the spectrum). The measurement results are evaluated and optionally monitored over an observation period by an evaluation and recording module 32 that is coupled to the detector 31. Module 32 may receive input data from the detector 31, process the input data, and output information for display on a display system and/or for storage (e.g., in a patient electronic medical record) in response to the processed input data, based on instruction or code programmed therein, corresponding to one or more routines. In particular, module 32 may be a microcomputer, including microprocessor unit, input/output ports, an electronic storage medium for executable programs and calibration values such as a read only memory chip, random access memory, keep alive memory, and a data bus. The storage medium read-only memory can be programmed with computer readable data representing instructions executable by the processor for performing the control methods for different components of
In the light source 21, laser-diode (e.g., λ=658 nm) can be used. A collimator lens may be used to make the input light beam L1 parallel, and a pinhole 23 of e.g. 0.5 mm may be used to reduce the beam diameter. For accurate measurements, a highly stable light source is required. However, even with a perfectly stable power source, temperature changes in the laser can cause drifting and random changes in the output.
To address this issue, the light source may optionally have an integrated input light monitoring diode 22 for measuring the output level of the laser. The (low-pass filtered) output of the monitoring sensor 22 can then be coupled to the evaluation module 32, which can divide the (low-pass filtered) optical signal from the detector 31 by the output of the monitoring sensor 22. For an improved signal-to-noise ratio, the resulting signal may be time-averaged. The division eliminates the effect of laser output fluctuations due to power variations (no stabilized power source needed) as well as temperature drift (no precautions like Peltier elements needed).
In some examples, the final output of the light source 21 may be measured. As
As mentioned above, the sensor system may be configured to measure optical signals using total internal reflection (TIR). For example, the light source emits a light beam into the aforementioned carrier such that it is totally internally reflected in an investigation region at the detection surface of the carrier. The “investigation region” may be a sub-region of the detection surface or comprise the complete detection surface; it will typically have the shape of a substantially circular spot that is illuminated by the input light beam. Moreover, it should be noted that the occurrence of total internal reflection requires that the refractive index of the carrier is larger than the refractive index of the material adjacent to the detection surface. This is for example the case if the carrier is made from glass (n=1.6) and the adjacent material is water (n=1.3). It should further be noted that the term “total internal reflection” shall include the case called “frustrated total internal reflection” (fTIR), where some of the incident light is lost (absorbed, scattered etc.) during the reflection process.
By utilizing fTIR, the detection technique is surface-specific, which may reduce background noise. FTIR results in the generation of an evanescent wave in the sample, which decays exponentially away from the surface of the carrier. When this evanescent wave interacts with another medium like the signal generating elements 1 in the setup of
While
Also shown in
The magnetic element 204 may be configured to generate a magnetic field having a gradient, with the highest density of the gradient (e.g., the highest magnetic flux) extending along a magnetic axis, which in
As shown in
As shown in
The magnetic element 204 causes magnetic field gradients toward the center of the sample cartridge, e.g., along the central axis 220. Because the magnetic element 204 has a longer length L2 than the length L1 of the sample cartridge 202, the magnetic field gradient may be consistent along the length L1 of the sample cartridge 202 but may vary along the width W1 of the sample cartridge 202. For example, along the central axis 220, the magnetic field may have a highest flux density along an entirety of the central axis 220 from the first side 306 to the second side 308. However, the magnetic flux density may decrease from the central axis 220 to the third side 402 and from the central axis 220 to the fourth side 404.
Thus, a magnetic field is generated when the magnetic element 204 is activated (e.g., current is supplied to the coil of the magnetic element 204). The magnetic field may have a gradient with a region of highest magnetic flux density positioned along the center of the sample cartridge, e.g., the central axis 220. After the sample is loaded into the sample cartridge 202, the signal generating elements are released and mix with the sample. When the magnetic element 204 is activated, the signal generating elements (which may be magnetic particles) and any bound analyte will be pulled to the detection surface 206 by magnetic force, and particularly be pulled toward the central axis 220, where the signal generating elements will interact with the capture elements fixed to the detection surface 206 (e.g., as the binding surface 205). Thus, the signal generating elements dispersed in the sample will concentrate toward the location of the highest field line density/highest magnetic flux density.
Accordingly, to ensure consistent analyte analysis, particularly when more than one analyte is being tested, the binding surface 205 may be positioned at or in proximity to the location of the highest field line density/flux density. For example, referring back to
While in the example shown in
The sample cartridge 202 is configured to be positioned in a sensor system, such as the sensor system of
After a threshold amount of time has elapsed, the biochemical reaction phase is stopped by applying a magnetic field that pulls unbound signal generating elements (e.g., signal generating elements that are not bound to the binding surface via the analyte and/or a capture element) away from the binding surface. Upon this magnetic washing, a detection phase commences, where optical fields are used to obtain a measurement of the number of signal generating elements that remain at the binding surface (due to the signal generating elements being bound to the binding surface). The optical signals measured during the detection phase, which may be referred to herein as sample data, are then compared to calibration information that may be predetermined and obtained from a tag on the sample cartridge, such as an RFID tag, in order to calculate the concentration of the analyte. Typically, the optical signals used to calculate the concentration of the analyte are obtained from specific pre-defined measurement regions of interest (ROIs) on the binding surface. These measurement ROIs may be subsets of the binding surface, e.g., rectangular areas that overlap the areas of the binding surface. Each measurement ROI may alternatively be the complete area of a respective binding surface area, or an area that includes a respective binding surface area as well as some area outside the respective binding surface area.
The testing process described above may result in variations in the optical signals detected at each measurement ROI and/or test-to-test optical signal variations due signal generating element distribution inhomogeneity and/or differing sample fluid parameters, such as viscosity. For example, a first patient being tested for an analyte concentration (e.g. troponin) may submit a sample (e.g., blood) having higher blood sugar content relative to a sample from a second patient. The higher sugar content may cause the signal generating elements in the sample from the first patient to have optical properties that differ from the signal generating elements in the sample from the second patient, as the optical properties of the signal generating elements are influenced by the material composition of the signal generating elements and the fluid surrounding the signal generating elements. In this way, the test results between the first patient and the second patient may vary due to the blood sugar content of the patients' blood samples, in addition to different levels of the analyte. Further, in some examples, different patient samples may exhibit different fluid viscosity, which may impact signal generating element mobility during testing, which may result in testing variations.
To address the above-described issues of signal generating element distribution inhomogeneities and different sample fluid properties, background data may be obtained during the biochemical reaction phase of the test (e.g., before applying the magnetic field to remove the unbound magnetic particles from the binding surface) or at another suitable time of the test and used to correct the sample data obtained during the detection phase. The background data may include optical signals that are obtained when bound and unbound magnetic particles are present at the binding surface, and thus may be obtained when the magnetic field is applied to actively pull the magnetic particles to the binding surface, but also could be obtained when magnetic fields are not being applied.
However, to further improve the correction of the sample data with the background data, the background data may include the measurement of optical signals from only unbound signal generating elements, as the concentration of the analyte will influence the binding of the signal generating elements to the binding surface. Thus, the background data may be obtained from background regions that do not overlap the binding surface.
The dark spots/streaks in
In the example shown in
While a sample cartridge configured to be positioned in a sensor device or sensor system has been described herein, it is to be appreciated that the sample cartridge may be any suitable container that is coated with one or more capture elements to form a binding surface thereof and configured to house a sample mixed with signal generating elements. For example, the sample cartridge may not be enclosed as described herein but may instead lack a top wall, or the sample cartridge may be in the form a plate including one or more wells. As such, the sample cartridge(s) described above with respect to
At 704, a reference measurement is optionally obtained. Obtaining the reference measurement may include activating one or more light sources of the sensor system and detecting the resultant optical signals with one or more detectors of the sensor system. The reference measurement may be obtained prior to the commencement of the biochemical reaction phase, e.g., prior to activation of a magnetic element of the sensor system. At 706, one or more magnetic elements of the sensor system are activated in order to attract the signal generating elements to the binding surface of the sample cartridge. The one or more magnetic elements may include one or more magnetic elements, such as magnetic element 204, that generate a magnetic field centered along a magnetic axis or a single point. The magnetic element(s) may be activated to generate a continuous or a pulsed magnetic field, according to a predetermined actuation protocol.
At 708, during the biochemical reaction phase where the one or more magnetic elements are being actuated according to the actuation protocol, one or more light sources of the sensor system are activated, such as light source 21, and detector data is obtained from one or more detectors, such as detector 31, to measure the optical signals at each background region of the sample container in order to generate background data. For example, the light source(s) positioned to direct light to the background regions may be activated and the resultant optical signals may be measured by corresponding detector(s). The collection of the background data may be timed to correspond with actuation periods where the magnetic field is being applied to pull the signal generating elements to the binding surface, at least in some examples. The optical signals may be obtained at one or more discrete time points during the biochemical reaction phase, or the optical signals may be obtained continuously during the biochemical reaction phase. In some examples, the optical signals may be obtained using FTIR based detection. In such examples, only the (magnetic) particles are detected that are in close proximity of the detection surface, e.g., within the evanescent wave which typically penetrates in the sample chamber by about 100 nm. Additionally, when using pulsed magnetic fields, the magnetic particles will not be close to the detection surface for the whole duration of a pulse (when the magnetic field is switched off for several 100 ms or seconds), and the measured signals thereby correspond to the effective time in which particles are at the detection surface (and can only then bind to the binding surface).
At 710, during the detection phase that commences after at least one magnetic wash has been performed (e.g., where a magnetic wash includes a magnetic field being applied to move unbound signal generating elements away from the binding surface of the sample container), one or more light sources are activated and detector data is obtained to measure the optical signals at each area of the binding surface in order to generate sample data. For example, the light source(s) positioned to direct light to the binding surface may be activated and the resultant optical signals may be measured by corresponding detector(s). The collection of the sample data may be performed only once the biochemical reaction phase is complete, in some examples. In other examples, the sample data may be collected at multiple time points during interruptions in the biochemical reaction phase. For example, the biochemical reaction phase may be paused so that a first sample dataset may be collected (after a magnetic wash is performed), and then the biochemical reaction phase may be resumed. Then the biochemical reaction phase may be terminated and a second sample dataset may be collected (after another magnetic wash is performed). By collecting sample data at one or more time points before the biochemical reaction phase is completed, signal saturation due to high analyte concentration, for example, may be avoided by measuring the optical signals before the biochemical reaction has gone to completion. The optical signals may be obtained at one or more discrete time points during the detection phase, or the optical signals may be obtained continuously during the detection phase. The timing of when the optical signals are obtained may be based on a desired signal to noise ratio of the signals (e.g., signals obtained closer to when the binding surface is saturated may have a higher signal to noise ratio) and/or a desired speed of performing the test. Further, similar to the background optical signals, the optical signals obtained to generate the sample data may be obtained using fTIR.
At 712, method 700 determines if the optical signals measured from each background region are non-zero signals. For example, the signal response detected from each background region during the collection of the background data may be analyzed to confirm that each region registered a positive, non-zero value from the output of the corresponding detector(s). Given the density of magnetic particles, at least some signal is expected to be measured from each background region. If no signal is detected (e.g., a zero value, or within a threshold range of zero) from one or more background regions, it may be indicative of an air bubble or otherwise a lack of the sample completely filling the sample container, which may compromise the test results. Thus, if one or more background regions register a signal of zero or register a signal within a threshold range of zero (e.g., the answer at 712 is NO), method 700 proceeds to 720 to display and/or store a notification that the current test is invalid and/or that the analyte concentration cannot be determined, and then method 700 returns.
However, if each background region has a positive, non-zero signal (e.g., the answer at 712 is YES), method 700 proceeds to 714 where the background data and the sample data are optionally corrected based on the reference measurement obtained at 704. For example, the reference measurement may be subtracted from each of the background data and the sample data. In doing so, other fluctuations that may affect the optical signal (e.g., output from the light sources) may be compensated. At 716, the sample data is corrected based on the background data. As explained previously, the background data from one or more background regions positioned adjacent or surrounding an area of the binding surface may be combined and used to correct the sample data for that area of the binding surface. In other examples, the background data from all the background regions may be combined and collectively used to correct the sample data from each area of the binding surface. Correcting the sample data based on the background data may include dividing the sample data by the background data. In other examples, a different function may be applied to correct the sample data using the background data, such as a relation between the sample data and the background data that is established during calibration, where the relation may be linear, a power function, exponential, etc.
In some examples, the background data may be weighted so that optical signals obtained from some background regions are given a higher weight than optical signals obtained from other background regions. For example, referring to
At 718, the corrected sample data may be stored and/or displayed on a display of the sensor system. The corrected sample data may be used to determine a concentration of one or more analytes of interest in the sample, and the determined concentration(s) or concentration signal(s) may be output for display and/or saved in memory. For example, the computing system may access a relationship between the corrected sample data and a concentration of an analyte (e.g., from an RFID tag on the sample container, from a relationship stored in memory, etc.) and determine the concentration of the analyte based on the corrected sample data and the relationship. For example, the concentration of the analyte may be computed using a calibration curve to convert the measured amount of bound signal generating elements into a concentration of the analyte. The calibration curve (or formula, or equation) may be stored in the memory of the sensor system (e.g., the evaluation and recording module 32), and the values/parameters for the calibration curve or formula may be stored onto an RFID tag of the sensor system. The calibration parameters (e.g., the calibration curve or formula, including constants of the formula) may be determined after manufacturing by testing a series of cartridges with reference samples, e.g., samples containing different concentrations of analyte, distributed over the reportable range for the test. The test data is then subsequently analyzed by fitting (e.g., a least squares regression) the data using a mathematical formula. The resulting fit parameters are then written onto the RFID tag of the device. Method 700 then ends.
As appreciated by
The limit of quantification (LoQ) 10% coefficient of variation (CV) (LoQ10% CV) was calculated for the uncorrected troponin concentration measurements and the corrected troponin concentration measurements and plotted as shown in
The improvement of the measured troponin concentration CV and LoQ10% CV due to the background correction was tested on additional batches of sample containers, as shown by graph 1200 of
When the background regions are positioned as shown in
At 1404, a reference measurement is optionally obtained. Obtaining the reference measurement may include activating one or more light sources of the sensor system and detecting the resultant optical signals with one or more detectors of the sensor system. The reference measurement may be obtained prior to the commencement of the biochemical reaction phase, e.g., prior to activation of a magnetic element of the sensor system. At 1406, one or more magnetic elements of the sensor system are activated in order to attract the signal generating elements to the binding surface of the sample cartridge. The one or more magnetic elements may include one or more magnetic elements, such as magnetic element 204, that generate a magnetic field centered along a magnetic axis or a single point. The magnetic element(s) may be activated to generate a continuous or a pulsed magnetic field, according to a predetermined actuation protocol.
At 1408, during the biochemical reaction phase where the one or more magnetic elements are being actuated according to the actuation protocol, one or more light sources of the sensor system are activated, such as light source 21, and detector data is obtained from one or more detectors, such as detector 31, to measure the optical signals at each background region of the sample container in order to generate background data. For example, the light source(s) positioned to direct light to the background regions may be activated and the resultant optical signals may be measured by corresponding detector(s). The collection of the background data may be timed to correspond with actuation periods where the magnetic field is being applied to pull the signal generating elements to the binding surface, at least in some examples.
At 1410, during the detection phase that commences after at least one magnetic wash has been performed (e.g., where a magnetic wash includes a magnetic field being applied to move unbound magnetic particles away from the binding surface of the sample container), one or more light sources are activated and detector data is obtained to measure the optical signals at each area of the binding surface in order to generate sample data. For example, the light source(s) positioned to direct light to the binding surface may be activated and the resultant optical signals may be measured by corresponding detector(s). The collection of the sample data may be performed only once the biochemical reaction phase is complete, in some examples. In other examples, the sample data may be collected at multiple time points during interruptions in the biochemical reaction phase. For example, the biochemical reaction phase may be paused so that a first sample dataset may be collected (after a magnetic wash is performed), and then the biochemical reaction phase may be resumed. Then the biochemical reaction phase may be terminated and a second sample dataset may be collected (after another magnetic wash is performed). By collecting sample data at one or more time points before the biochemical reaction phase is completed, signal saturation due to high analyte concentration, for example, may be avoided by measuring the optical signals before the biochemical reaction has gone to completion.
At 1412, the background data and the sample data are optionally corrected based on the reference measurement obtained at 1404. For example, the reference measurement may be subtracted from each of the background data and the sample data. In doing so, other fluctuations that may affect the optical signal (e.g., output from the light sources) may be compensated. At 1414, the sample data is subtracted from the background data to generate corrected background data. As explained above, the optical signals measured during the biochemical reaction phase include signals from both bound and unbound signal generating elements, as the optical signals are measured at the capture element spots (because the background regions overlap the binding surface). Thus, the signals from only the unbound signal generating elements are obtained by removing the optical signals obtained when the biochemical reaction phase is complete, which is indicative of the optical signals of only the bound signal generating elements. The corrected background data may include a separate corrected background dataset for each background region, or the background data may be combined and the combined sample data may be subtracted from the combined background data.
At 1416, the sample data is corrected based on the corrected background data. Correcting the sample data based on the corrected background data may include dividing the sample data by the corrected background data. In other examples, a different function may be applied to correct the sample data using the background data, such as a relation between the sample data and the background data that is established during calibration, where the relation may be linear, a power function, exponential, etc.
At 1418, the corrected sample data may be stored and/or displayed on a display of the sensor system. The corrected sample data may be used to determine a concentration of one or more analytes of interest in the sample, similar to the process described above with respect to
While the methods discussed above with respect to
Thus, by measuring the sensor signals from the signal generating elements during the magnetic attraction phase, the combined effects of sample properties and signal generating element distribution inhomogeneities (and possibly other causes) that influence the signal response can be measured and used to directly correct the signal response of the binding surface. By using the signal response from the signal generating elements outside the binding surface areas (e.g., such that the background data is obtained in one or more regions of the detection surface that are not functionalized with capture elements), the background correction is not influenced by the concentration of the analyte(s) being tested, which may influence the signal response within the binding surface also during the magnetic attraction phase (e.g., during this phase, the signal response will increase over time dependent on the analyte concentration). Another advantage of the background correction described herein is that the signals measured outside the binding surface during the biochemical reaction (when magnetic particles are at the binding surface) can be used as a check for the correction functioning of the reaction. For example, if the reaction chamber is not fully filled with liquid but instead contains air inclusions, a signal near zero will be measured at the location of the air inclusion, indicating signal generating elements cannot reach this location area of the detection surface. This information can then be used to invalidate the test and prevent erroneous test results from being released.
The technical effect of correcting sample data indicative of a number of signal generating elements bound to a binding surface based on background data indicative of a number of unbound signal generating elements is that gravitational and fluid composition effects on a concentration of an analyte determined based on the sample data may be compensated, thereby reducing test-to-test variability.
The disclosure also provides support for a sensor system, comprising a sample container configured to receive a sample containing an analyte to be tested, the sample container comprising: a detection surface, and a plurality of signal generating elements in the sample container, wherein the detection surface comprises a binding surface, which has been partially functionalized with capture elements that can bind, directly and/or indirectly, the analyte and/or the plurality of signal generating elements, and a memory storing instructions executable by a processor to: obtain background data comprising sensor signals from one or more background regions of the detection surface, obtain sample data comprising sensor signals from the binding surface, and perform a correction of the sample data based on the background data. In a first example of the system, the one or more background regions of the detection surface are each arranged in an at least partially non-overlapping manner with the binding surface. In a second example of the system, optionally including the first example, the system further comprises: a magnetic element, and wherein the magnetic element is activated to generate a magnetic field to pull the plurality of signal generating elements to the binding surface while the background data is obtained, and the magnetic element is not activated to generate the magnetic field or the magnetic element is activated to keep unbound signal generating elements away from the binding surface while the sample data is obtained. In a third example of the system, optionally including one or both of the first and second examples, at least a portion of signal generating elements of the plurality of signal generating elements includes a capture element that can bind the analyte. In a fourth example of the system, optionally including one or more or each of the first through third examples, the instructions are executable to weight the sensor signals from at least one background region differently than at least one other background region. In a fifth example of the system, optionally including one or more or each of the first through fourth examples, the binding surface comprises a plurality of discrete areas, each area of the binding surface functionalized with the capture elements, and wherein the one or more background regions of the detection surface are each arranged in a non-overlapping manner with the plurality of discrete areas of the binding surface such that each background region is not functionalized with capture elements. In a sixth example of the system, optionally including the one or more or each of first through fifth examples, the plurality of discrete areas of the binding surface is arranged into a first row of areas and a second row of areas, and wherein the one or more background regions of the detection surface comprise a plurality of background regions arranged into a first row of background regions, a second row of background regions, and a third row of background regions. In a seventh example of the system, optionally including one or more or each of the first through sixth examples, the first row of background regions are located proximate a pinning of the sample container, the third row of background regions are located proximate an inlet of the sample container, and the second row of background regions are located intermediate the first row of background regions and the third row of background regions, and wherein the sensor signals for the one or more background regions are weighted such that the sensor signals from the first row of background regions and the third row of background regions are given a higher weight than the sensor signals from the second row of background regions. In an eighth example of the system, optionally including one or more or each of the first through seventh examples, each background region of the detection surface overlaps a respective area of the binding surface. In a ninth example of the system, optionally including one or more or each of the first through eighth examples, the instructions are executable to subtract the sample data from the background data to generate corrected background data, and wherein correcting the sample data based on the background data comprises correcting the sample data based on the corrected background data. In a tenth example of the system, optionally including one or more or each of the first through ninth examples, the instructions are executable to determine a concentration of the analyte in the sample based on the corrected sample data. In an eleventh example of the system, optionally including one or more or each of the first through tenth examples, the instructions are executable to determine the concentration of the analyte in the sample based on the corrected sample data in response to positive, non-zero optical signals being obtained from each of the one or more background regions, and in response to positive, non-zero optical signals not being obtained from each of the one or more background regions, output a notification indicating that the concentration of the analyte cannot be determined.
The disclosure also provides support for a method for a sensor system, comprising during a test of a sample including an analyte contained in a sample container of the sensor system, measuring sensor signals at one or more background regions of a detection surface of the sample container to generate background data, measuring sensor signals at a binding surface of the sample container to generate sample data, wherein the binding surface comprises one or more areas of the detection surface that are functionalized with capture elements that can bind, directly and/or indirectly, the analyte and/or a plurality of signal generating elements of the sample container, and outputting a concentration of the analyte in the sample based on the sample data and the background data. In a first example of the method, the sensor signals at the one or more background regions are measured while the plurality of signal generating elements are being pulled to the binding surface and wherein the sensor signals at the binding surface are measured while the plurality of signal generating elements are not being pulled to the binding surface. In a second example of the method, optionally including the first example, the sensor signals comprise optical signals measured using frustrated total internal reflection.
References to “one embodiment” or “an embodiment” do not necessarily refer to the same embodiment, although they may. Unless the context clearly requires otherwise, throughout the description and the claims, the words “comprise,” “comprising,” and the like are to be construed in an inclusive sense as opposed to an exclusive or exhaustive sense; that is to say, in the sense of “including, but not limited to.” Words using the singular or plural number also include the plural or singular number respectively, unless expressly limited to a single one or multiple ones. Additionally, the words “herein,” “above,” “below” and words of similar import, when used in this application, refer to this application as a whole and not to any particular portions of this application. When the claims use the word “or” in reference to a list of two or more items, that word covers all of the following interpretations of the word: any of the items in the list, all of the items in the list and any combination of the items in the list, unless expressly limited to one or the other.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/EP2021/084960 | 12/9/2021 | WO |
Number | Date | Country | |
---|---|---|---|
63127428 | Dec 2020 | US |